Moderna fourth-quarter revenue beats estimates

Investing.com -- Moderna Inc (NASDAQ: MRNA) has reported a steep drop in fourth-quarter revenue to $2.81 billion, but still topped average analyst expectations.

Shares in the U.S. drugmaker were higher in premarket trading on Thursday.

This is a developing story. Please check back later for updates.

You May Also Be Interested In

• HSBC explains why risk assets continue to ignore every negative catalyst
• Morgan Stanley cuts Peloton rating on structural fitness headwinds
• Justice Department halts antitrust cooperation with Canada - report